Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy

This publication has 12 references indexed in Scilit:

• Should Tumor Mitotic Rate and Patient Age, As Well As Tumor Thickness, be Used to Select Melanoma Patients for Sentinel Node Biopsy?
  Annals of Surgical Oncology, 2004
• Age and the Incidence of Sentinel Lymph Node Metastases in Melanoma
  Annals of Surgical Oncology, 2004
• Mitotic Rate and Younger Age Are Predictors of Sentinel Lymph Node Positivity: Lessons Learned From the Generation of a Probabilistic Model
  Annals of Surgical Oncology, 2004
• Correlation Between Prognostic Factors and Increasing Age in Melanoma
  Annals of Surgical Oncology, 2004
• Sentinel Lymph Node Biopsy Does not Change Melanoma-Specific Survival Among Patients with Breslow Thickness Greater than Four Millimeters
  Annals of Surgical Oncology, 2004
• Multivariate prognostic model for patients with thick cutaneous melanoma: Importance of sentinel lymph node status
  Annals of Surgical Oncology, 2002
• Improved Staging of Node-Negative Patients With Intermediate to Thick Melanomas (>1 mm) With the Use of Lymphatic Mapping and Sentinel Lymph Node Biopsy
  Annals of Surgical Oncology, 2001
• Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)
  Annals of Surgical Oncology, 2000
• Validation of the Accuracy of Intraoperative Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage Melanoma
  Annals of Surgery, 1999
• Prognosis of thick cutaneous melanoma
  Journal of the American College of Surgeons, 1999